These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

380 related items for PubMed ID: 8794181

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. KLF10 gene expression is associated with high fetal hemoglobin levels and with response to hydroxyurea treatment in β-hemoglobinopathy patients.
    Borg J, Phylactides M, Bartsakoulia M, Tafrali C, Lederer C, Felice AE, Papachatzopoulou A, Kourakli A, Stavrou EF, Christou S, Hou J, Karkabouna S, Lappa-Manakou C, Ozgur Z, van Ijcken W, von Lindern M, Grosveld FG, Georgitsi M, Kleanthous M, Philipsen S, Patrinos GP.
    Pharmacogenomics; 2012 Oct; 13(13):1487-500. PubMed ID: 23057549
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Sickle cell anemia: targeting the role of fetal hemoglobin in therapy.
    Coleman E, Inusa B.
    Clin Pediatr (Phila); 2007 Jun; 46(5):386-91. PubMed ID: 17556734
    [Abstract] [Full Text] [Related]

  • 27. Sickle cell paths converge on hydroxyurea.
    Platt OS.
    Nat Med; 1995 Apr; 1(4):307-8. PubMed ID: 7585059
    [No Abstract] [Full Text] [Related]

  • 28. Pharmacologic manipulation of fetal hemoglobin. Update on clinical trials with hydroxyurea.
    Dover GJ.
    Ann N Y Acad Sci; 1990 Apr; 612():184-90. PubMed ID: 1705407
    [No Abstract] [Full Text] [Related]

  • 29. Hydroxyurea and sickle cell disease: a chance for every patient.
    Weiner DL, Brugnara C.
    JAMA; 2003 Apr 02; 289(13):1692-4. PubMed ID: 12672739
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The therapeutic reactivation of fetal haemoglobin.
    Olivieri NF, Weatherall DJ.
    Hum Mol Genet; 1998 Apr 02; 7(10):1655-8. PubMed ID: 9735388
    [Abstract] [Full Text] [Related]

  • 32. Hydroxyurea increases fetal hemoglobin production in sickle cell anemia.
    Platt OS, Orkin SH, Dover G, Beardsley GP, Miller B, Nathan DG.
    Trans Assoc Am Physicians; 1984 Apr 02; 97():268-74. PubMed ID: 6085528
    [No Abstract] [Full Text] [Related]

  • 33. Hydroxycarbamide for sickle-cell anaemia in infancy.
    Weatherall DJ.
    Lancet; 2011 May 14; 377(9778):1628-30. PubMed ID: 21571132
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Therapies to increase fetal hemoglobin in sickle cell disease.
    Steinberg MH.
    Curr Hematol Rep; 2003 Mar 14; 2(2):95-101. PubMed ID: 12901139
    [Abstract] [Full Text] [Related]

  • 36. [Fetal hemoglobin].
    Rokicka-Piotrowicz M.
    Postepy Hig Med Dosw; 1989 Mar 14; 43(5-6):475-97. PubMed ID: 2484927
    [Abstract] [Full Text] [Related]

  • 37. The effect of hydroxyurea on the coagulation system in sickle cell anemia and beta-thalassemia intermedia patients: a preliminary study.
    Koc A, Gumruk F, Gurgey A.
    Pediatr Hematol Oncol; 2003 Sep 14; 20(6):429-34. PubMed ID: 14631615
    [Abstract] [Full Text] [Related]

  • 38. Induction of fetal hemoglobin in sickle cell patients by hydroxyurea: the N.I.H. experience.
    Rodgers GP, Dover GJ, Noguchi CT, Schechter AN, Nienhuis AW.
    Prog Clin Biol Res; 1989 Sep 14; 316B():281-93. PubMed ID: 2482498
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.